173,401 Waters Corporation $WAT Shares Sold by Cooke & Bieler LP

Posted by Brian Himes on Oct 22nd, 2026

Cooke & Bieler LP cut its position in shares of Waters Corporation (NYSE:WAT – Free Report) by 82.7% during the third quarter, Holdings Channel.com reports. The firm owned 36,335 shares of the medical instruments supplier’s stock after selling 173,401 shares during the quarter. Cooke & Bieler LP’s holdings in Waters were worth $15,965,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Anchor Investment Management LLC purchased a new stake in shares of Waters in the 1st quarter valued at approximately $27,000. Resources Management Corp CT ADV acquired a new stake in shares of Waters during the 1st quarter worth approximately $27,000. PenderFund Capital Management Ltd. acquired a new stake in shares of Waters during the 2nd quarter worth approximately $28,000. Vision Retirement LLC purchased a new stake in shares of Waters during the 1st quarter valued at approximately $29,000. Finally, Bollard Group LLC purchased a new stake in shares of Waters during the 1st quarter valued at approximately $29,000. 94.01% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Waters

In related news, Director Christopher Kuebler sold 3,626 shares of the business’s stock in a transaction on Thursday, August 6th. The stock was sold at an average price of $397.94, for a total value of $1,442,930.44. Following the sale, the director owned 17,808 shares in the company, valued at approximately $7,086,515.52. The trade was a 16.92% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 0.31% of the company’s stock.

Waters Stock Up 3.6%

Waters stock opened at $458.74 on Thursday. The company has a market capitalization of $45.07 billion, a PE ratio of 114.40, a price-to-earnings-growth ratio of 2.58 and a beta of 1.15. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.29 and a current ratio of 1.86. Waters Corporation has a fifty-two week low of $282.77 and a fifty-two week high of $459.63. The firm has a 50 day moving average price of $422.72 and a 200 day moving average price of $379.82.

Waters (NYSE:WAT – Get Free Report) last released its quarterly earnings results on Tuesday, August 4th. The medical instruments supplier reported $3.05 EPS for the quarter, topping analysts’ consensus estimates of $3.01 by $0.04. Waters had a return on equity of 11.27% and a net margin of 3.58%. The company had revenue of $1.65 billion for the quarter, compared to analysts’ expectations of $1.62 billion. During the same period in the prior year, the firm earned $2.95 earnings per share. The firm’s revenue was up 113.3% compared to the same quarter last year. Waters has set its Q3 2026 guidance at 3.950-4.050 EPS and its FY 2026 guidance at 14.450-14.650 EPS. Research analysts expect that Waters Corporation will post 14.56 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of research analysts recently commented on the company. Stifel Nicolaus set a $420.00 price objective on Waters in a report on Wednesday, August 5th. Weiss Ratings raised Waters from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday, October 8th. Wells Fargo & Company raised their target price on Waters from $370.00 to $400.00 and gave the stock an “equal weight” rating in a research note on Wednesday, August 5th. Evercore restated an “outperform” rating and issued a $420.00 target price on shares of Waters in a research report on Wednesday, August 5th. Finally, Royal Bank Of Canada lifted their target price on Waters from $435.00 to $475.00 and gave the company an “outperform” rating in a research report on Wednesday, August 5th. Two research analysts have rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and six have given a Hold rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $443.79.

Read Our Latest Stock Report on Waters

Waters Company Profile

(Free Report)

Waters Corporation (NYSE:WAT) develops and manufactures analytical technologies used to measure, identify and characterize chemical and biological substances. Its customers include pharmaceutical and biotechnology companies, industrial manufacturers, academic and government laboratories, and organizations involved in food, environmental and clinical testing.

The company’s product portfolio includes high-performance liquid chromatography and ultra-performance liquid chromatography systems, mass spectrometers, chromatography columns and consumables, and laboratory software for data management and analysis.